Microvast Earnings Call Highlights Profit Turnaround

Microvast Holdings, Inc. ((MVST)) has held its Q4 earnings call. Read on for the main highlights of the call.

Microvast Holdings, Inc. used its latest earnings call to spotlight a turnaround year, pairing record revenue and a return to adjusted profitability with strong cash generation and robust regional growth. Management acknowledged notable GAAP headwinds, including a large inventory impairment and regulatory issues in Asia, but stressed that operational gains and technology milestones put the company on a firmer long‑term footing.

Record Revenue and Volume Growth

Microvast reported record 2025 revenue of $427.5 million, up 12.6% from $379.8 million a year earlier as sales volume expanded about 16.5% to roughly 266 MWh. The volume-led growth signals rising adoption of its battery solutions and shows that demand held up despite pockets of regional pressure and regulatory change.

Return to Adjusted Profitability

The company swung to a non‑GAAP adjusted net profit of $13.0 million in 2025, reversing a $84.6 million adjusted loss in 2024 and marking a significant improvement in the underlying economics of the business. Management framed this as evidence that prior investments and cost actions are now translating into sustainable profitability, even before further capacity ramps.

Positive Adjusted EBITDA and Operating Turnaround

Non‑GAAP adjusted EBITDA came in at $44.7 million, a sharp swing from negative $44.8 million in 2024 that underscores improved operating leverage as scale builds. On a GAAP basis, Microvast also moved to an operating profit of $6.98 million from a $116.1 million loss, while operating cash flow surged to $75.9 million from just $2.8 million.

Regional Growth Led by U.S. and EMEA

Geographically, U.S. revenue jumped 173% year over year to $39.3 million, now representing about 9% of total sales and highlighting early traction in a key strategic market. EMEA revenue grew 13% to $211.9 million, remaining roughly half of the company’s business and reinforcing Europe as a core demand engine.

Solid Liquidity and Balance Sheet

Microvast ended 2025 with $169.2 million in cash, cash equivalents and restricted cash, a net increase of $59.6 million over the year that gives it flexibility to fund capacity expansions. Management emphasized that positive operating cash flow, rather than new capital raises, was the primary driver of this stronger liquidity position.

Product and Technology Progress

On the technology front, Microvast highlighted trial production of its 55 Ah cell and next‑generation LTO cells, alongside Huzhou Phase 3.2 trial runs that target about 2 GWh of added capacity. The company also reported progress in all‑solid‑state development, including a 12‑layer monolithic stack surpassing 200 cycles with 99.97% Coulombic efficiency and a 72V stack reaching 100 cycles.

Lower Operating Expenses and Leaner Cost Base

Total operating expenses dropped to $118.3 million from $238.3 million in 2024, reflecting a more disciplined cost structure as the business scales. General and administrative costs fell 29% and R&D expenses declined 16.9%, with lower share-based compensation contributing to the step‑down across the expense base.

Inventory Impairment Weighs on Margins

Despite the top-line and cash‑flow gains, Microvast recorded a $32.5 million inventory impairment related to specialized ESS components that meaningfully hurt reported profitability. The charge reduced full‑year gross margin by 7.6 percentage points and was cited as a key driver of the divergence between solid non‑GAAP metrics and weaker GAAP results.

GAAP Net Loss and Earnings Volatility

On a GAAP basis, the company posted a net loss of $29.2 million for 2025 even as adjusted figures turned positive, underscoring the impact of impairment and valuation items. Management pointed to $38.3 million of impairment and disposals, $39.1 million of fair value changes on warrants and a convertible loan, and share‑based adjustments as sources of earnings volatility.

Q4 Headwinds and APAC Pressure

Fourth‑quarter revenue of $96.4 million came in soft as regulatory changes in South Korea and slower than expected platform ramps in EMEA pushed some demand out, leaving full‑year sales just below guidance. APAC revenue slipped 1% to $176.3 million, and management flagged Korean regulatory uncertainty as an ongoing headwind that could cap near‑term regional growth.

Ramp and Timing Risks at Huzhou Phase 3.2

The Huzhou Phase 3.2 expansion, currently in trial production, is slated to add around 2 GWh of capacity and is seen as central to Microvast’s growth trajectory. Management acknowledged that ramp timing, associated 2025 CapEx of $19.8 million and the costs of moving to serial production in 2026 could pressure margins if demand and production are not tightly synchronized.

Guidance and Forward-Looking Outlook

Looking to 2026, Microvast expects continued revenue growth as Huzhou Phase 3.2 transitions to serial production and the Clarksville pack line begins customer deliveries, expanding total available capacity. The company aims to stay cash‑flow positive and protect what it describes as industry‑leading margins, while carefully pacing capacity ramps to customer demand in a backdrop of evolving tariffs and geopolitical risk.

Microvast’s latest earnings call painted a picture of a company moving past heavy investment years toward a more self‑funding, scalable model, even as GAAP numbers remain lumpy. For investors, the key watchpoints will be execution on Huzhou Phase 3.2, navigating regulatory pressures in Asia and converting strong technology progress into sustained profitable growth across its global footprint.